- 1H26 revenue/adj. PATMI exceeded our expectations, at 84%/94% of our FY26e forecasts. Guthrie’s results were consolidated for the full 1H26, driving revenue and PATMI outperformance. Adj. PATMI accelerated 208% YoY to S$14.1mn, driven by progress of the combined M&E projects, including maintenance of street lighting and bus depot facilities upgrades.
- Order book surged 220% YoY to more than S$1bn. Ever Glory secured more than S$400mn new contracts in 2026, including S$168mn combined value for an offshore defence infrastructure project and M&E contracts in commercial mixed developments. We believe Ever Glory can secure additional high-value M&E contracts going forward. Potential awards include Integrated General Hospital (>S$200mn per M&E project), Changi T5 buildings and runway lighting (S$1bn or more for M&E), and LTA MRT tunnel lighting projects.
- We maintain BUY with a higher TP of S$1.20 (prev. S$1.05). We raised FY26e revenue/PATMI by 57% and 62% respectively, due to the consolidation of Guthrie’s results. We estimate about 13% share dilution since 2025. The bulk came from the September 2025 placement (57%), half of whose net proceeds funded the Guthrie purchase, and from the conversion of the S$5mn convertible bond (32%). The enlarged share base is justified. Ever since the acquisition of Guthrie in 2H25, Ever Glory’s order book increased by more than 3x to more than S$1bn. 1H26 adj. PATMI accelerated 208% YoY to S$14.1mn from the consolidation of Guthrie’s results, far offsetting the effects of share dilution.
Continue Reading

